Anand B Karnad

Fingerprint Dive into the research topics where Anand B Karnad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

1 Finished

INSTITUTE FOR CANCER RESEARCH AND CARE

Hinck, A. P., Sarantopoulos, J., Curiel, T. J., Lafer, E. M., Weintraub, S. E., Karnad, A. B., Lechleiter, J. D., Thompson, I. M., Leach, R. J., Christy, B. A., Allred, C., Johnson, K., Padmanabhan, S., I-Tien, Y., Naylor, S., Gazitt, Y., Pollock, B. H., Mundy, G., Bonewald, L., Davis, S., Lee, E., Oishi, N., Hasty, E., Vijg, J. N. M. N., Herman, B. A., Johnson, K., Moyer, M., Windle, J., McGill, J., O'Connell, P., Clark, G., Kuhn, J., Wolf, R., Allred, D. C., Weiss, G., Boldt, D., Coltman, C. & Huang, H.

National Institutes of Health

9/1/91 → 7/31/19

Project: Research project

Research Output

1227 Citations
20 h-Index
44 Article
13 Letter
13 Review article
3 Comment/debate
2 More
- 2 Editorial

Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study

Herbst, R. S., Redman, M. W., Kim, E. S., Semrad, T. J., Bazhenova, L., Masters, G., Oettel, K., Guaglianone, P., Reynolds, C., Karnad, A., Arnold, S. M., Varella-Garcia, M., Moon, J., Mack, P. C., Blanke, C. D., Hirsch, F. R., Kelly, K. & Gandara, D. R., Jan 2018, In : The Lancet Oncology. 19, 1, p. 101-114 14 p.

Research output: Contribution to journal › Article

22 Scopus citations

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma

Kelly, K. R., Friedberg, J. W., Park, S. I., McDonagh, K., Hayslip, J., Persky, D., Ruan, J., Puvvada, S., Rosen, P., Iyer, S. P., Stefanovic, A., Bernstein, S. H., Weitman, S., Karnad, A., Monohan, G., VanderWalde, A., Mena, R., Schmelz, M., Spier, C., Groshen, S. & 5 others, Venkatakrishnan, K., Zhou, X., Sheldon-Waniga, E., Jane Leonard, E. & Mahadevan, D., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6150-6159 10 p.

Research output: Contribution to journal › Article

7 Scopus citations

The biology and role of CD44 in cancer progression: Therapeutic implications

Chen, C., Zhao, S., Karnad, A. B. & Freeman, J. W., May 10 2018, In : Journal of Hematology and Oncology. 11, 1, 64.

Research output: Contribution to journal › Review article

82 Scopus citations

Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

Fountzilas, C., Stuart, S., Hernandez, B., Bowhay-Carnes, E., Michalek, J. E., Sarantopoulos, J., Karnad, A. B., Patel, S., Weitman, S. D. & Mahalingam, D., Jan 19 2017, (Accepted/In press) In : Investigational New Drugs. p. 1-6 6 p.

Research output: Contribution to journal › Article

3 Scopus citations

Safety and pharmacodynamics of the PDE4 inhibitor roflumilast in advanced B-cell malignancies

Kelly, K., Mejia, A., Suhasini, A. N., Lin, A. P., Kuhn, J., Karnad, A. B., Weitman, S. D. & Aguiar, R. C., Mar 1 2017, In : Clinical Cancer Research. 23, 5, p. 1186-1192 7 p.

Research output: Contribution to journal › Article